Global Clinical Trials: The Role of Emerging Markets

Track:
Clinical Operations

Day & Time:
June 24, 2:30PM - 4:00PM

Session Number:
126

Room Number:
206AB

Level:
Intermediate

Type:
Symposium

Title:
Global Clinical Trials: The Role of Emerging Markets

Chair(s):
Nancy Meyerson-Hess, MSc
Compound Development and Branding
Gruenenthal, Germany

Description:
Today’s drug development relies on global clinical trials which include emerging markets. The symposium will address performance, best practices, strategies and challenges of undertaking global clinical trials. The speakers will provide examples from global clinical trials with a focus on reducing risks, optimizing strategy to improve site enrollment and overall performance, and experience from the Clinical Trial Consortium in the Asia Pacific region.

Learning Objective(s):
Describe the areas of potential risks when undertaking global clinical trials in emerging markets; Compare industry emerging markets activity and strategy as it relates to overall strategy, patient recruitment practices and randomization; Evaluate the various mechanisms to speed up the clinical trial approval process in the Asia Pacific region.

Presentation(s) & Speaker(s):
Reducing the Risks of Integrating Emerging Regions in Global Clinical Trials
Nancy Meyerson-Hess, MSc
Compound Development and Branding
Gruenenthal, Germany

Establishment of a Clinical Trial Consortium in the Asia Pacific Region
Guei-Jen Shieh, PhD
Director, Clinical Group
National Research Program For Biopharmaceuticals , Taiwan

Clinical Trials in Emerging Markets: Trends and Experience Study Highlights
Linda Martin, MBA
Principal and Founder
KMR Group Inc., United States